Cardiac and Brain Damages

Acute myocardial infarction (AMI) and resulting complications are among the primary causes of mortality and morbidity in the western world. Modern biochemical markers, being much more specific and sensitive, play a consolidated role in the diagnosis and even in the risk stratification of patients suffering from ischemic myocardial disease. Following the publication of the commonly recognized consensus document of the American College of Cardiology and the European Society of Cardiology, the measurement of cardiac troponins has become the cornerstone of the diagnosis of AMI as well as for the evaluation of patients suffering coronary artery disease (CAD).
During the last decade the analysis of Neuro-biochemical markers for brain damage has attracted increasing attention in a variety of Central Nervous System (CNS) disorders.
These markers are expected to provide insight into the pathophysiological pathways of brain damage, independent of clinical evaluation and other diagnostic procedures, thereby making them useful tools for diagnosis, monitoring or prognosis of brain damaged patients.